NCT06448793已完成不适用
Patient and Physician Preferences for Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer Treatments
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 650
- 试验地点
- 2
- 主要终点
- Responses to qualitative interview questions
研究概览
简要总结
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged ≥18 years at the time of enrollment in the study
- •Resident of the US, Germany, or Japan
- •Able to read, speak, and understand English, German or Japanese
- •Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC)
- •Resident of the US, Germany, or Japan
- •Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology
- •Treated at least three new patients with resectable NSCLC in the past year
排除标准
- •Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
- •Being diagnosed with another malignancy alongside NSCLC
- •Not willing to be audio-recorded during the interview
- •Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment)
- •Not willing to be audio-recorded during the interview
研究组 & 干预措施
Patients with a diagnosis of resectable non-small cell lung cancer (NSCLC)
干预措施: Approved Non-small Cell Lung Cancer (NSCLC) therapies (Drug)
Physicians currently treating resectable non-small cell lung cancer (NSCLC) patients
干预措施: Approved Non-small Cell Lung Cancer (NSCLC) therapies (Drug)
结局指标
主要结局
Responses to qualitative interview questions
时间窗: Day 1
Interview questions designed to gather insights into diagnosis, symptoms, current treatments, perspectives on treatment features and test for mock preferences tasks. The interview will take 15 minutes to complete.
Patient clinical characteristics
时间窗: Day 1
Patient sociodemographic
时间窗: Day 1
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Patient and Provider Attitudes in the Healthcare ContextHypertensionDiabetes MellitusNCT00404027VA Office of Research and Development300
已完成
不适用
The PAtient Preference Analysis of Yearly Follow-up After PCI (PAPAYA)Coronary Artery DiseaseNCT02189070Thorax Centrum Twente2,566
已完成
不适用
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And PortugalRenal Cell CarcinomaNCT05168436Bristol-Myers Squibb105
已完成
不适用
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyMetastatic Hormone-sensitive Prostate CancerProstate CancerNCT05381311Astellas Pharma Global Development, Inc.1,020
已完成
不适用
Qualitative Research Among Physicians and Junior Doctors Into the Preconditions for Implementing a CDSS Based on AI in the ICUArtificial IntelligenceQualitative ResearchDecision Support Systems, ClinicalNCT05303025University Ghent69